Scientific deep-dive

Ozempic and Penis Size: What Weight Loss Changes and What It Does Not

No study has measured penile length on semaglutide or tirzepatide, and neither drug acts on penile tissue. Losing the fat pad over the pubic bone can expose more of the shaft. What the measured studies show, and when hidden length becomes buried penis.

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
9 min read·21 citations

Part of Body changes and sexual health on a GLP-1

No study has measured penile length in men taking semaglutide or tirzepatide, and there is no evidence that either drug acts on penile tissue. The penis does not grow. What changes with weight loss is the pad of fat over the pubic bone, which in heavier men covers the base of the shaft. When that pad shrinks, more of the shaft is visible. In one fat-reduction study, thinning the suprapubic fat by about a centimeter added about 0.8 cm of length measured from the skin to the tip.[6] The underlying anatomical length, measured from the pubic bone, is not what moves.[3][5]

About this article. Findings come from published urology and sexual-medicine studies, and adverse-event counts from FDA’s public database, all linked in the references. None of these studies tested a GLP-1 drug on penile measurements; where a conclusion is drawn from weight-loss or fat-removal studies, the text labels it as inference. Erectile function is covered separately in GLP-1 drugs and erectile dysfunction, and hormones and sperm in GLP-1 drugs, testosterone and male fertility. This is not medical advice.

The short answer, claim by claim

What is and is not supported about GLP-1 drugs and penile size
ClaimEvidenceStatus
Semaglutide or tirzepatide makes the penis growNo study has measured it. No known action of these drugs on penile tissue.Not supported
Losing suprapubic fat exposes more of the shaftFat removal raised skin-to-tip length in two small studies.[5][6]Supported, small studies
Adult weight changes anatomical lengthIn 290 men, adult BMI was not linked to measured length once other factors were counted.[3]Not supported
Weight loss lets more men see the penisAfter bariatric surgery, men who could see it rose from 40% to 91% in a survey.[8]Supported, self-report
The drugs shrink the penisFive FAERS reports for semaglutide use that term. Reports are not proof of cause.[19]Not established

Visible length and anatomical length are different measurements

Most of the confusion comes from which length is being measured. Urologists use several. Stretched length, the penis gently pulled to full length while flaccid, tracks erect length most closely.[2] In a pooled review of studies where a clinician did the measuring, mean stretched length was 13.24 cm across more than 14,000 men, and mean erect length 13.12 cm.[1] The measurement that tracks body size most consistently in that review was height, not weight.[1]

The second distinction is where the ruler starts. A measurement can begin at the skin where the penis meets the abdomen, or the ruler can be pressed through the fat to the pubic bone. In a lean man the two are nearly the same. In a man with a thick suprapubic fat pad, the skin-to-tip number is shorter, because part of the shaft sits behind fat. A 2025 study of 290 men measured both. Waist circumference was linked to a shorter skin-to-tip flaccid length, while current adult BMI showed no significant link to any length once the other factors were accounted for. The authors concluded that adult obesity mainly changes how the penis looks rather than its real size.[3]

A man who measures himself at home, from the skin, before and after losing 40 pounds, is therefore measuring fat as much as anatomy. A change in that number is real in the sense that more shaft is visible. It is not tissue growth.

What happens to visible length when suprapubic fat is removed

There are no studies of drug-induced weight loss and penile measurement in adult men. The closest direct evidence comes from procedures that remove suprapubic fat on purpose. They are small, mostly from single clinics, and none was randomized.

Studies that measured penile length before and after suprapubic fat was reduced
StudyWho and whatWhat was measuredResult
Ghanem 2017[5]10 men complaining of a small penis, suprapubic liposuctionSkin-to-tip flaccid and stretched length, before and 3 months afterBoth rose significantly (p < 0.001). The authors note shaft length was normal to begin with.
Azab 2021[6]46 men, three sessions of fat freezing (cryolipolysis) over the pubic areaApparent stretched length and suprapubic skinfoldLength 12.1 → 12.66 → 12.88 cm; skinfold 2.99 → 2.37 → 2.0 cm
Ma 2025[7]120 obese children, 30 days of supervised diet with or without a physical programStretched and flaccid lengthDiet-only group: stretched 4.03 → 4.40 cm, flaccid 2.01 → 2.77 cm

The cryolipolysis study is the most useful for scale. Removing roughly a centimeter of skinfold thickness over the pubic bone was associated with about 0.8 cm more visible stretched length.[6] The children’s study is the only one in which weight loss itself, rather than a procedure, came before the measurement. It found gains in exposed length after 30 days, but it was in children, its intervention is only partly described in the English abstract, and children are still growing.[7]

Inference, not finding: a man who loses substantial weight on a GLP-1 and loses suprapubic fat along with it would be expected to see a similar change in visible length. How much depends on how thick the fat pad was, and no study has measured it in GLP-1 users. There is no published ratio of centimeters gained per pound lost, despite figures that circulate online.

What weight-loss surgery patients report

The nearest evidence to large medical weight loss comes from bariatric surgery. A 2026 survey from the University of California, San Francisco asked 64 men, an average of about four years after surgery, about urination, genital anatomy and sex. Eleven, 17%, reported having had trouble exposing the penis to urinate or have sex before surgery. Of those men, only 8% could see their penis beforehand and 45% had problems with genital infections.[8]

Both groups reported improvement after weight loss. The only change that reached statistical significance was in men without the buried-penis problem: the share who could see their penis rose from 40% to 91%.[8] That is a self-reported, retrospective survey with a small sample, and it measured visibility, not length. It is consistent with the fat-pad explanation and with nothing more.

Weight loss does not always fix concealment. After massive weight loss, the fat can go but the stretched skin of the lower abdomen can remain as an apron that hangs over the genitals. Plastic surgeons describe this as a separate pattern, sometimes called pseudo-buried penis, in which the shaft is not retracted into fat but simply covered by loose skin.[9] It is corrected by removing the excess skin, not by more weight loss. Timing that surgery after GLP-1 weight loss is covered in when it is safe to have the skin removed.

Buried penis: when hidden length is a medical problem

At the far end of the same process is a recognized condition, adult acquired buried penis. The shaft becomes trapped below the surface of the suprapubic fat and surrounding skin. Obesity is the most common cause. Genital lymphedema, hidradenitis suppurativa, trauma and scarring after circumcision can also cause it or make it worse.[10][9] Reviewers describe it as increasingly common as obesity rises.[10][14]

It is not a cosmetic complaint. Urine can spray or pool against the skin, which stays wet, and men may be unable to urinate standing or to keep the area clean.[9][11] The trapped skin is prone to infection and to lichen sclerosus, a chronic scarring skin disease, which in turn can narrow the urethra. The case series are consistent:

  • Lichen sclerosus. 23% of 180 men having buried-penis surgery at one center had it on pathology. Men with it needed stricture surgery more than twice as often: 54.8% against 23.8%.[15]
  • Urethral stricture. Rates of 33% and 47% in two surgical series.[17][12]
  • Penile cancer. 7% of 150 men with the condition at one referral center had penile squamous cell carcinoma, and 35% had premalignant lesions.[16] A later series from the same center found cancer in 5%.[15] These are referral populations, not general rates.
  • Sexual function and mood. Reviews describe effects on sexual function, self-image and mental health.[11][10]

One practical consequence: if the penis cannot be seen, it cannot be examined. One group recommends repair partly for that reason.[16]

How buried penis is treated

Established buried penis is treated surgically. Depending on severity, repair ranges from releasing the shaft with local skin, to skin grafts over the shaft, to removing the suprapubic fat pad (escutcheonectomy), reshaping the scrotum, and removing the lower abdominal apron (panniculectomy).[12][11] In one series of 64 repairs, 91% of men were successfully unburied, and those who needed the most complex operations had a median BMI of 48 against 36 for simpler repairs.[12] In another, all 12 men who answered a follow-up survey reported better hygiene and 92% said they would have the operation again.[13]

Weight matters for the result. In 76 men repaired at the University of Washington, 22% had the penis become buried again over an average of about 14 months. A BMI of 40 or more was associated with 12.7 times the odds of recurrence, and every one-point rise in BMI added 12% to those odds. The authors suggest counseling patients on weight loss before surgery.[14] That is where a GLP-1 drug may have a role, as one route to the weight loss surgeons ask for. No study has yet tested GLP-1 treatment before buried-penis repair.

When to see a urologist. Trouble seeing or reaching the penis to urinate, urine spraying or soaking the skin, recurring infections or rashes, white or scarred patches on the foreskin or glans, a weakening urine stream, or any sore or lump that does not heal. These are reasons for an examination regardless of whether you are losing weight.

Why the drugs cannot add tissue in adults

Penile growth happens during puberty and is driven by testosterone. Obesity during childhood appears to interfere with it: in 1,130 Italian boys, penile growth was about 10% lower in obese boys than in normal-weight boys, alongside lower testosterone.[4] In the 2025 Vietnamese study, obesity before puberty was associated with shorter adult stretched and pubic-to-tip length, while adult obesity was not.[3] Once growth is complete, there is no evidence that later weight change, by any method, alters the anatomical length of the shaft.

GLP-1 drugs can raise testosterone in men whose low levels are driven by excess weight, which is covered in our testosterone and fertility review. A rise in adult testosterone does not restart penile growth. Erection quality is a separate matter: an erection that is firmer or fuller can look larger, and the evidence on GLP-1 drugs and erectile function is mixed. That is the subject of the erectile dysfunction page.

How much weight GLP-1 users actually lose

Visible change depends on losing enough fat to thin the pad over the pubic bone. STEP 1 enrolled 1,961 adults. At 68 weeks, mean weight change was −14.9% with weekly semaglutide 2.4 mg and −2.4% with placebo.[20] In SURMOUNT-1, 2,539 adults on tirzepatide 15 mg lost 20.9% over 72 weeks, against 3.1% on placebo.[21] Where the fat comes off is not uniform, and neither trial measured suprapubic fat. Some men will notice a change and others will not.

Weight loss of this size also takes lean tissue with it. How much, and how it compares with surgery, is set out in fat-to-muscle ratio: surgery versus drugs.

Reports of shrinkage, and other genital side effects

The opposite claim also circulates. In FDA’s adverse event reporting system, five reports for semaglutide carry the coded term “penile size reduced,” out of about 73,000 semaglutide reports in the public dataset. There are none for tirzepatide among about 160,000.[19] These are voluntary reports. They show that someone described the event, not that the drug caused it, and they cannot give a rate.

One published case describes genital symptoms rather than size. A 40-year-old man developed urinary frequency, penile itching, painful urination, pelvic pain and sexual dysfunction three to four weeks after starting tirzepatide, with negative tests for infection. The symptoms resolved within ten days of stopping the drug and did not come back.[18] A single case cannot show cause. Side effects across the class are compared in which GLP-1 has the worst side effects.

Frequently Asked Questions

No. No study has measured penile length in men on semaglutide, and nothing suggests the drug acts on penile tissue. Weight loss can shrink the fat pad over the pubic bone, which exposes more of the shaft and can make the penis look longer. The anatomical length does not change.
Not in tissue terms. Tirzepatide produces larger average weight loss than semaglutide, so some men lose more suprapubic fat and see more of the shaft. That is a change in visibility. No trial of tirzepatide measured penile length.
There is no reliable figure for drug-induced weight loss. In a study of 46 men whose suprapubic fat was reduced by fat freezing, apparent stretched length rose from 12.1 to 12.9 cm as the skinfold thinned by about a centimeter. Results depend on how much fat covered the base to begin with.
There is no evidence that it does. FDA's public database holds five reports for semaglutide coded as reduced penile size, among about 73,000 semaglutide reports. Reports show that someone described an event, not that the drug caused it.
A medical condition in which the penis is trapped below the suprapubic fat and skin, most often because of obesity. It can cause urine to pool on the skin, infections, lichen sclerosus, urethral narrowing and, in referral series, higher rates of penile cancer. Established cases are treated with surgery.
Sometimes it helps, and surgeons often recommend weight loss before repair because a BMI of 40 or more raises the odds that the penis becomes buried again. But scarring and loose skin left after large weight loss can keep it covered, and established cases usually need surgery.

References

  1. 1.Veale D, Miles S, Bramley S, et al. Am I normal? A systematic review and construction of nomograms for flaccid and erect penis length and circumference in up to 15,521 men BJU Int. 2015. PMID: 25487360.
  2. 2.Wessells H, Lue TF, McAninch JW Penile length in the flaccid and erect states: guidelines for penile augmentation J Urol. 1996. PMID: 8709382.
  3. 3.Nguyen BH, Pham QM, Nguyen ABQ, et al. Associations between obesity across the lifespan and adult penis dimensions: a retrospective observational study of Vietnamese men using 3D-modeled prepubertal BMI J Sex Med. 2025. PMID: 40751588.
  4. 4.Mancini M, Pecori Giraldi F, Andreassi A, et al. Obesity Is Strongly Associated With Low Testosterone and Reduced Penis Growth During Development J Clin Endocrinol Metab. 2021. PMID: 34283215.
  5. 5.Ghanem H, ElKhaiat YI, Motawi AT, AbdelRahman IF Infrapubic Liposuction for Penile Length Augmentation in Patients with Infrapubic Adiposities Aesthetic Plast Surg. 2017. PMID: 28155063.
  6. 6.Azab SS, Hamed HA, Elseginy A, et al. Increase apparent penile length by cryolipolysis in the reduction of male suprapubic fat Andrologia. 2021. PMID: 33426693.
  7. 7.Ma YN, Pu WT, Nafisa T, et al. Physical intervention combined with medical nutritional weight loss for the treatment of short penis in obese children (article in Chinese) Zhonghua Nan Ke Xue. 2025. PMID: 40787954.
  8. 8.Dick B, Lopez A, Grant R, et al. Adult acquired buried penis and bariatric surgery: a mighty motivator Transl Androl Urol. 2026. PMID: 41809786.
  9. 9.Mirastschijski U Classification and Treatment of the Adult Buried Penis Ann Plast Surg. 2018. PMID: 29668507.
  10. 10.Staniorski CJ, Rusilko PJ The concealed morbidity of buried penis: a narrative review of our progress in understanding adult-acquired buried penis as a surgical condition Transl Androl Urol. 2021. PMID: 34295741.
  11. 11.Smith-Harrison LI, Piotrowski J, Machen GL, Guise A Acquired Buried Penis in Adults: A Review of Surgical Management Sex Med Rev. 2020. PMID: 31101591.
  12. 12.Pariser JJ, Soto-Aviles OE, Miller B, et al. A Simplified Adult Acquired Buried Penis Repair Classification System With an Analysis of Perioperative Complications and Urethral Stricture Disease Urology. 2018. PMID: 29898381.
  13. 13.Voznesensky MA, Lawrence WT, Keith JN, Erickson BA Patient-Reported Social, Psychological, and Urologic Outcomes After Adult Buried Penis Repair Urology. 2017. PMID: 28132851.
  14. 14.Chestnut C, Koch G, Stewart A, et al. Increased body mass index is associated with recurrence and complications following repair for adult acquired buried penis J Sex Med. 2025. PMID: 40580946.
  15. 15.Daly WC, Klein RD, Myrga JM, et al. Lichen Sclerosus in Patients Undergoing Adult-Acquired Buried Penis Repair: A Large Cohort Review Urology. 2025. PMID: 40752848.
  16. 16.Pekala KR, Pelzman D, Theisen KM, et al. The Prevalence of Penile Cancer in Patients With Adult Acquired Buried Penis Urology. 2019. PMID: 31369750.
  17. 17.Liaw A, Rickborn L, McClung C Incidence of Urethral Stricture in Patients with Adult Acquired Buried Penis Adv Urol. 2017. PMID: 28465682.
  18. 18.Tariq A, Garza Gangemi A, Herrera Caceres J Beyond weight loss: Effect of GLP-1 receptor agonist therapy on the urological health Urol Case Rep. 2026. PMID: 41716526.
  19. 19.U.S. Food and Drug Administration openFDA drug adverse event API (FAERS): semaglutide and tirzepatide reports coded “penile size reduced”, data through July 2026 openFDA. 2026. https://api.fda.gov/drug/event.json?search=patient.drug.openfda.generic_name:SEMAGLUTIDE+AND+patient.reaction.reactionmeddrapt.exact:%22PENILE+SIZE+REDUCED%22&limit=1
  20. 20.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) N Engl J Med. 2021. PMID: 33567185.
  21. 21.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) N Engl J Med. 2022. PMID: 35658024.

Does Ozempic Cause Erectile Dysfunction? What the Evidence Shows

No GLP-1 label lists erectile dysfunction and no semaglutide or tirzepatide trial has measured erections. One database study found more ED after Ozempic; better-controlled studies and a dulaglutide trial did not. Plus Viagra and Cialis with a GLP-1.

12 min read

GLP-1s and Sex Drive: What Ozempic and Mounjaro Do to Libido in Men and Women

No large trial has measured whether Ozempic, Wegovy, Mounjaro or Zepbound lowers sex drive, and no US label mentions libido. What the one controlled trial, rodent studies, case reports and FDA adverse-event data show, and the ordinary causes to rule out first.

11 min read

Ozempic Vulva: What the Evidence Shows About Fat Loss and the Labia

No GLP-1 trial or label has measured the vulva. The mons pubis and labia majora are mostly fat, and these drugs remove fat everywhere. What plastic surgeons see after large weight loss, and what fillers, fat grafting and surgery can and cannot do.

10 min read

GLP-1 Drugs and Your Breasts: Size, Pain, Mammograms and Cancer Risk

No trial has measured breast changes on Ozempic, Wegovy, Mounjaro or Zepbound. What bariatric imaging studies show about breast volume, why no label lists breast pain, how weight loss alters mammogram density, and what randomized trials say about breast cancer.

10 min read

L-Carnitine Injections for Weight Loss: What the Evidence Shows

No trial shows L-carnitine shots cause weight loss. Oral carnitine trials average about 1.2 kg over placebo; the only approved injection, Carnitor, is for deficiency and dialysis, IV only. What TMAO studies show, and what carnitine adds to a GLP-1 vial.

11 min read

PT-141 (Bremelanotide): What the Evidence Shows

PT-141 is bremelanotide, approved as Vyleesi only for low sexual desire in premenopausal women. Its phase 3 trials found small gains in desire and no rise in satisfying sexual events. The men's program stopped in 2007 over blood pressure.

11 min read

Where to get tirzepatide (Mounjaro / Zepbound) online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.1

MyDrHank

An oral route if you will not self-inject

8.7

Eden

Coverage in all 50 states, which most sellers will not confirm

8.6

SnagRx

Semaglutide at $99/month, well below the typical price